Last reviewed · How we verify
NCT06199050: ENGAGE
The Effect of 360° Virtual Reality Movies on Fear and Anxiety
NA trial testing Questionnaire: SPIRIT in Fear in 292 participants. Completed in 13 May 2025.
13 May 2025
Quick facts
| Lead sponsor | Maastricht Radiation Oncology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 292 |
| Start date | 16 June 2023 |
| Primary completion | 13 May 2025 |
| Estimated completion | 13 May 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Questionnaire: SPIRIT
- Questionnaire: HADS
- Questionnaire: QSC-R23
- General questions
- Clinical data collected
Conditions studied
- Fear — all drugs for Fear →
- Anxiety — all drugs for Anxiety →
- Breast Cancer — all drugs for Breast Cancer →
- Lung Cancer — all drugs for Lung Cancer →
Sponsor
Maastricht Radiation Oncology — full company profile →
Who can join
18 and older, any sex, with Fear or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the effect of web-based 360° Virtual Reality movies on fear and anxiety, The investigators would like to assess the patient-perceived level of fear and anxiety quantitatively, making use of several questionnaires.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Contemporary Role of Virtual and Augmented Reality in Radiation Oncology: A Review.
Mohssine S, Pelland MÈ, Bedwani S, Roberge D. · · 2026 · PMID 42187596 · DOI 10.3390/curroncol33050279
Verify or expand the search:
- PubMed search for NCT06199050
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fear
Currently open trials in the same condition.
- NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
- NCT07404163 — Walkway Used in Postoperative Mobilization · NA · active not recruiting
- NCT07378995 — The Effect of Therapeutic Play Applied Before Intramuscular Injection · NA · recruiting
- NCT07379021 — Mindfulness-Based Emotion Regulation Training for Hospitalized Children · NA · recruiting
- NCT07255365 — Virtual Reality-Based 360° Clinic Walkthrough for Reducing Examination Anxiety in Preschool Children · NA · recruiting
Other Maastricht Radiation Oncology trials
Trials by the same sponsor.
- NCT07501845 — Registry Maastro Applicator · recruiting
- NCT07004582 — Lab Research Using Mini-tumors to Study Prostate Cancer Treatments · not yet recruiting
- NCT06024941 — Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer · Phase 2 · withdrawn
- NCT05182437 — Precision Radiation Treatment for Epilepsy (PRECISION) · NA · active not recruiting
- NCT02432417 — The Addition of Chloroquine to Chemoradiation for Glioblastoma, · Phase 2 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06199050 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maastricht Radiation Oncology
- Last refreshed: 2 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06199050.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing